CSF1 and central nervous system cancer: CSF-1/CSF-1R is the essential signaling pathway for macrophage survival and proliferation, but the CSF-1R inhibitor BLZ945 suppresses glioma growth and progression by altering macrophage polarization, but not by depleting macrophages 104, and improves the survival rate of glioma mice 105.